ReJoycetherapy

In addition to several completed trials funded by the Canadian Institutes of Health Research and Spinal Research UK, as well as three multi-centre clinical trials underway funded by the SCI-Solutions Network, Canadian Spinal Cord Injury Telerehabilitation and the Victorian Neurotrauma Initiative (Australian ReJoyce SCI Trials), ReJoyce is now part of two more studies coordinated by researchers at the University of Alberta in Edmonton. The first study compares two levels of FES and ReJoyce-based rehabilitation on the recovery of hand function in chronic stroke survivors: FES and ReJoyce. The second study, also based in Edmonton, investigates the effect of a new type of FES implant in combination with ReJoyce-based therapy on people with SCI.

For more information, please contact us.